Skip to content

ACIU

AC Immune S.A.

NASDAQ · CHHealthcareBiotechnology
$2.20+0.92%

Price as of Jul 17, 2026

ACIU earnings

AC Immune S.A. earnings

Reported EPS and revenue history, upcoming estimates and available earnings-call summaries.

Next earnings
Aug 4, 2026in NaN days
EPS est $0.10 · Revenue est $34M
Track record
Beat EPS in 9 of 12 quarters
Avg surprise +8.3% (last 4 quarters)
Earnings history
Report dateEPS estEPS actualSurpriseRevenueRev. surprise
Apr 30, 2026$-0.20$-0.19+5.0%$1M+325.0%
Mar 13, 2026$-0.21$-0.18+14.6%$223731-56.8%
Nov 4, 2025$-0.22$-0.20+9.1%$1M+3.2%
Apr 30, 2025$-0.22$-0.21+4.5%$1M+145.4%
Mar 13, 2025$-0.21$-0.18+14.3%$1M+52.8%
Mar 14, 2024$-0.07$-0.06+14.3%$17M+51.3%
Nov 3, 2023$-0.02$-0.20-754.3%
Aug 4, 2023$-0.22$-0.22+0.0%
Apr 28, 2023$-0.24$-0.23+4.2%
Mar 16, 2023$-0.28$-0.24+14.3%$1081-99.9%
Oct 28, 2022$-0.24$-0.17+29.2%$4M+1028.1%
Jul 28, 2022$-0.24$-0.24+0.0%

Earnings history is derived from company filings and calendar data. Call summaries are grouped by reporting period. Latest covered event: 2026-08-04.